Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Facial Plast Surg ; 2023 Dec 13.
Article in English | MEDLINE | ID: mdl-37992751

ABSTRACT

The potential benefits to surgical outcomes of intraoperative and/or same-day computed tomography (CT) during isolated orbital fracture reconstruction are debatable, and previous research on this topic is limited by small sample size. This retrospective IBM MarketScan Commercial and Medicare Supplemental research database study examined patients undergoing isolated orbital reconstruction from January 1, 2012 to December 31, 2018, to assess whether same-day CT affected postoperative outcomes. The average age of the 5,023 participants was 37 (standard deviation [SD]: 16) years and 63% were males. The data revealed that 16.2% (815 of 5,023) patients underwent a same-day CT. Those who underwent a same-day CT scan exhibited reduced odds of postoperative enophthalmos (adjusted odds ratio [aOR]: 0.269; 95% confidence interval [CI]: 0.167-0.433) and diplopia (aOR: 0.670; 95% CI: 0.495-906). Interestingly, these patients also displayed a higher rate of revision surgeries (aOR: 2.721; 95% CI: 1.893-3.912). In summary, while same-day CT scans diminish certain postoperative complications of orbital fracture repair, they are also associated with an increased likelihood of subsequent surgical revision.

2.
Facial Plast Surg Aesthet Med ; 25(6): 548-555, 2023.
Article in English | MEDLINE | ID: mdl-37782903

ABSTRACT

Background: Intraoperative computed tomography (CT) allows surgeons to make adjustments during orbital fracture repair that may impact postoperative outcomes. Learning/Study Objectives: To determine the impact of intraoperative CT use on intraoperative revision and surgical outcomes for orbital fracture repair. Methods: A systematic review was performed in concordance with the Preferred Reporting Items of Systematic Reviews and Meta-Analyses (PRISMA) guidelines: the population was patients undergoing orbital fracture repair; intervention was use of intraoperative CT; comparison was patients not undergoing intraoperative CT; and outcomes were intraoperative revision rate, postoperative complications, and secondary revision surgeries. Meta-analysis was performed on the rate of intraoperative revision. Results: The search criteria yielded 790 articles, 377 were eligible for review, and 20 articles met criteria for analysis. In 19, intraoperative imaging led to immediate surgical corrections, with a random pooled effect size of 0.27 (0.20-0.35). Six studies reported secondary revision surgery rates (range 0-10.5%), and six studies reported postoperative complication rates (range 10-30%). Conclusions: Intraoperative imaging helps surgeons make precise, real-time adjustments in 27% of orbital fracture repair cases, which may improve surgical outcomes; however, more research is needed to investigate its impact on health care costs, operating time, and radiation exposure.


Subject(s)
Orbital Fractures , Plastic Surgery Procedures , Humans , Orbital Fractures/diagnostic imaging , Orbital Fractures/surgery , Tomography, X-Ray Computed/methods , Reoperation , Intraoperative Care , Postoperative Complications/surgery
3.
Facial Plast Surg ; 2023 Jul 27.
Article in English | MEDLINE | ID: mdl-37336502

ABSTRACT

Several known factors affect outcomes of Mohs facial defect reconstruction; however, the effect of repair timing on outcomes is ill-defined. The aim of this study was to determine postoperative complication rates between immediate and delayed repair of Mohs facial defects. Preferred Reporting Items of Systematic Reviews and Meta-Analyses guidelines were used. Articles were selected using PICO format-population: Mohs facial defect patients, intervention: defect repair, comparator: immediate (<24 hours), or delayed (>24 hours) repair, outcome: complication rate. PubMed/Medline (1946-2020), EMBASE (1947-2020), Scopus (1823-2020), Web of Science (1900-2020), Cochrane Library, and Clinicaltrials.gov were searched. Two independent reviewers screened abstracts; those in English with human subjects reporting repair timing and complication rates were included. Search criteria yielded 6,649 abstracts; 233 qualified for review. Data were gathered from six studies; they alone contained comparative data meeting inclusion criteria. While many well-written studies were encountered, reported results varied widely. A statistically sound meta-analysis could not be completed due to large heterogeneity between studies, biasing the analysis towards the largest weighted study. Clinically important differences may exist between immediate and delayed Mohs reconstruction, but small study numbers, large heterogeneity, and lack of standardized outcome measures limit definitive conclusions. More studies are needed to perform appropriate meta-analyses, including studies using standardized methods of reporting Mohs outcome data.

5.
Clin Plast Surg ; 49(1): 61-70, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34782140

ABSTRACT

Controlling the nasal tip to achieve excellent structural and cosmetic outcomes is challenging in rhinoplasty surgery. A strong foundation and understanding of the nasal tripod complex and the various methods for restoring tip support mechanisms when disrupted either from surgery or other means is critical. The columellar strut graft, septal extension graft, and tongue-in-groove suture technique are well-described methods to control and support the nasal tip. There are advantages and disadvantages to each method, but one should be comfortable with the nuances of each to master nasal tip surgery.


Subject(s)
Nose , Rhinoplasty , Humans , Nasal Septum/surgery , Nose/surgery , Prostheses and Implants , Suture Techniques
6.
Ann Otol Rhinol Laryngol ; 126(9): 646-653, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28770621

ABSTRACT

OBJECTIVE: To evaluate perioperative pain in patients undergoing major head and neck cancer surgery and identify associations between preoperative and postoperative pain characteristics. METHODS: Patients undergoing head and neck surgery with regional/free tissue transfer were enrolled. Preoperative pain and validated screens for symptoms (neuropathic pain, anxiety, depression, fibromyalgia) were assessed. Postoperatively, patients completed a pain diary for 4 weeks. RESULTS: Twenty-seven patients were enrolled. Seventy-eight percent had pain prior to surgery, and for 38%, the pain had neuropathic characteristics. Thirteen patients (48%) completed at least 2 weeks of the postoperative pain diary. Patients with moderate/severe preoperative pain report significantly greater pain scores postoperatively, though daily pain decreased at a similar linear rate for all patients. Patients with more severe preoperative pain consumed greater amounts of opioids postoperatively, and this correlated with daily postoperative pain scores. Patients who screened positive for neuropathic pain also reported worse postoperative pain. CONCLUSION: Longitudinal perioperative pain assessment in head and neck patients undergoing surgery suggests that patients with worse preoperative pain continue to endorse worse pain postoperatively and require more narcotics. Patients with preoperative neuropathic pain also report poor pain control postoperatively, suggesting an opportunity to identify these patients and intervene with empiric neuropathic pain treatment.


Subject(s)
Cancer Pain/physiopathology , Carcinoma, Squamous Cell/surgery , Head and Neck Neoplasms/surgery , Neuralgia/physiopathology , Otorhinolaryngologic Surgical Procedures , Pain, Postoperative/physiopathology , Skin Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Ameloblastoma/complications , Ameloblastoma/surgery , Analgesics, Opioid/therapeutic use , Anxiety/psychology , Cancer Pain/etiology , Cancer Pain/psychology , Carcinoma, Adenoid Cystic/complications , Carcinoma, Adenoid Cystic/surgery , Carcinoma, Squamous Cell/complications , Depression/psychology , Female , Head and Neck Neoplasms/complications , Humans , Linear Models , Longitudinal Studies , Male , Melanoma/complications , Melanoma/secondary , Melanoma/surgery , Middle Aged , Neuralgia/etiology , Neuralgia/psychology , Pain Measurement , Pain, Postoperative/drug therapy , Pain, Postoperative/epidemiology , Pain, Postoperative/psychology , Parotid Neoplasms/complications , Parotid Neoplasms/surgery , Perioperative Period , Preoperative Period , Severity of Illness Index , Skin Neoplasms/complications , Skin Neoplasms/pathology , Squamous Cell Carcinoma of Head and Neck
7.
Free Radic Biol Med ; 108: 354-361, 2017 07.
Article in English | MEDLINE | ID: mdl-28389407

ABSTRACT

D-penicillamine (DPEN), a copper chelator, has been used in the treatment of Wilson's disease, cystinuria, and rheumatoid arthritis. Recent evidence suggests that DPEN in combination with biologically relevant copper (Cu) concentrations generates H2O2 in cancer cell cultures, but the effects of this on cancer cell responses to ionizing radiation and chemotherapy are unknown. Increased steady-state levels of H2O2 were detected in MB231 breast and H1299 lung cancer cells following treatment with DPEN (100µM) and copper sulfate (15µM). Clonogenic survival demonstrated that DPEN-induced cancer cell toxicity was dependent on Cu and was significantly enhanced by depletion of glutathione [using buthionine sulfoximine (BSO)] as well as inhibition of thioredoxin reductase [using Auranofin (Au)] prior to exposure. Treatment with catalase inhibited DPEN toxicity confirming H2O2 as the toxic species. Furthermore, pretreating cancer cells with iron sucrose enhanced DPEN toxicity while treating with deferoxamine, an Fe chelator that inhibits redox cycling, inhibited DPEN toxicity. Importantly, DPEN also demonstrated selective toxicity in human breast and lung cancer cells, relative to normal untransformed human lung or mammary epithelial cells and enhanced cancer cell killing when combined with ionizing radiation or carboplatin. Consistent with the selective cancer cell toxicity, normal untransformed human lung epithelial cells had significantly lower labile iron pools than lung cancer cells. These results support the hypothesis that DPEN mediates selective cancer cell killing as well as radio-chemo-sensitization by a mechanism involving metal ion catalyzed H2O2-mediated oxidative stress and suggest that DPEN could be repurposed as an adjuvant in conventional cancer therapy.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/pharmacology , Breast Neoplasms/drug therapy , Chelating Agents/pharmacology , Epithelial Cells/drug effects , Lung Neoplasms/drug therapy , Penicillamine/pharmacology , Auranofin/pharmacology , Breast Neoplasms/pathology , Breast Neoplasms/radiotherapy , Buthionine Sulfoximine/pharmacology , Carboplatin/pharmacology , Catalase/metabolism , Cell Line, Tumor , Copper/chemistry , Copper/metabolism , Epithelial Cells/physiology , Female , Humans , Hydrogen Peroxide/metabolism , Lung Neoplasms/pathology , Lung Neoplasms/radiotherapy , Oxidative Stress , Radiation , Thioredoxin-Disulfide Reductase/antagonists & inhibitors
8.
Physician Leadersh J ; 4(2): 16-21, 2017 Mar.
Article in English | MEDLINE | ID: mdl-30571878

ABSTRACT

Positive response to a major university's project designed to gauge interest in business and management among medical students leads to implementation of a new curriculum for the next wave of physician leaders.


Subject(s)
Commerce/education , Commerce/organization & administration , Curriculum , Education, Medical, Undergraduate/organization & administration , Students, Medical/psychology , Adult , Female , Humans , Male , Young Adult
9.
PLoS One ; 9(11): e112126, 2014.
Article in English | MEDLINE | ID: mdl-25393878

ABSTRACT

Nuclear Interactor of ARF and Mdm2 (NIAM, gene designation Tbrg1) is a largely unstudied inhibitor of cell proliferation that helps maintain chromosomal stability. It is a novel activator of the ARF-Mdm2-Tip60-p53 tumor suppressor pathway as well as other undefined pathways important for genome maintenance. To examine its predicted role as a tumor suppressor, we generated NIAM mutant (NIAM(m/m)) mice homozygous for a ß-galactosidase expressing gene-trap cassette in the endogenous gene. The mutant mice expressed significantly lower levels of NIAM protein in tissues compared to wild-type animals. Fifty percent of aged NIAM deficient mice (14 to 21 months) developed proliferative lesions, including a uterine hemangioma, pulmonary papillary adenoma, and a Harderian gland adenoma. No age-matched wild-type or NIAM(+/m) heterozygous animals developed lesions. In the spleen, NIAM(m/m) mice had prominent white pulp expansion which correlated with enhanced increased reactive lymphoid hyperplasia and evidence of systemic inflammation. Notably, 17% of NIAM mutant mice had splenic white pulp features indicating early B-cell lymphoma. This correlated with selective expansion of marginal zone B cells in the spleens of younger, tumor-free NIAM-deficient mice. Unexpectedly, basal p53 expression and activity was largely unaffected by NIAM loss in isolated splenic B cells. In sum, NIAM down-regulation in vivo results in a significant predisposition to developing benign tumors or early stage cancers. These mice represent an outstanding platform for dissecting NIAM's role in tumorigenesis and various anti-cancer pathways, including p53 signaling.


Subject(s)
Cell Transformation, Neoplastic/genetics , DNA-Binding Proteins/genetics , Genetic Predisposition to Disease , Lymphoma, B-Cell/genetics , Adenoma/genetics , Animals , Cell Proliferation/genetics , Down-Regulation , Female , Hemangioma/genetics , Humans , Hyperplasia/genetics , Male , Mice , Mice, Transgenic , Signal Transduction , Tumor Suppressor Protein p53
SELECTION OF CITATIONS
SEARCH DETAIL